Point-of-Care Molecular Diagnostics Market Size, Share, Growth Analysis, By Technology(PCR-based, Genetic Sequencing-based, Hybridization-based, Microarray-based), By Application Type(Infectious Diseases, HIV POC, Clostridium difficile POC, HBV POC), By Location(OTC, POC), By End-use(Decentralized Labs, Hospitals, Home-care, Assisted Living Health Care Facilities), By Regional(North America, Europe, Asia Pacific, Latin America) - Industry Forecast 2024-2031

Segmentation Analysis:

The Point-of-Care Molecular Diagnostics Market is segmented by Technology, Application Type, Location, End-use, Regional. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future.

• Based on Technology the market is segmented as, PCR-based, Genetic Sequencing-based, Hybridization-based, Microarray-based
• Based on Application Type the market is segmented as, Infectious Diseases, HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV POC, Other Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, Other Applications
• Based on Location the market is segmented as, OTC, POC
• Based on End-use the market is segmented as, Decentralized Labs, Hospitals, Home-care, Assisted Living Health Care Facilities, Others
• Based on Regional the market is segmented as, North America, Europe, Asia Pacific, Latin America